Actuate Therapeutics, Inc.
ACTUNasdaqCIK 1652935HealthcareFiscal year ends Dec 31
Reports and events: 45 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2817:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-008143 |
| 2026-10-1908:00 ET | S-1/A | Registration statement, amended | 0001683168-26-007941 |
| 2026-10-1408:01 ET | S-1/A | Registration statement, amended | 0001683168-26-007832 |
| 2026-10-0616:52 ET | S-1 | Registration statement | 0001683168-26-007661 |
| 2026-08-1416:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001683168-26-006472 |
| 2026-07-1716:30 ET | 8-K | 3.01 Delisting notice | 0001683168-26-005616 |
| 2026-05-2216:43 ET | 8-K | 5.07 Shareholder vote results | 0001683168-26-004268 |
| 2026-05-1416:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001683168-26-003909 |
| 2026-05-1117:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-003684 |
| 2026-05-0609:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-003515 |
| 2026-04-0616:06 ET | DEF 14A | Proxy statementPeriod 2026-05-21 | 0001683168-26-002691 |
| 2026-03-2616:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001683168-26-002257 |
| 2026-01-1216:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-000217 |
| 2025-11-2817:21 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-008732 |
| 2025-11-2116:30 ET | 8-K | 8.01 Other events | 0001683168-25-008618 |
| 2025-11-1316:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001683168-25-008323 |
| 2025-09-1017:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-006831 |
| 2025-08-1416:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001683168-25-006159 |
| 2025-07-2516:00 ET | S-1 | Registration statement | 0001683168-25-005402 |
| 2025-06-3012:08 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-063957 |
| 2025-06-2608:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-25-004766 |
| 2025-06-0514:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-004258 |
| 2025-06-0207:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-004117 |
| 2025-05-2716:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-052987 |
| 2025-05-2316:10 ET | 8-K | 5.07 Shareholder vote results | 0001683168-25-003995 |
| 2025-05-1516:08 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001683168-25-003705 |
| 2025-05-0608:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-003163 |
| 2025-04-0816:15 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001683168-25-002344 |
| 2025-03-2806:23 ET | S-1 | Registration statement | 0001683168-25-001948 |
| 2025-03-2806:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-25-001945 |
| 2025-03-1316:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001683168-25-001581 |
| 2025-02-0716:30 ET | 8-K | 8.01 Other events | 0001683168-25-000826 |
| 2024-12-1716:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-008794 |
| 2024-11-1316:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001683168-24-007971 |
| 2024-11-1208:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-007857 |
| 2024-09-2416:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001683168-24-006623 |
| 2024-08-1920:59 ET | SC 13D | Ownership report, active investor | 0001104659-24-090990 |
| 2024-08-1917:25 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-24-005919 |
| 2024-08-1416:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-089693 |
| 2024-07-2306:01 ET | S-1/A | Registration statement, amended | 0001104659-24-081626 |
| 2024-07-1907:58 ET | S-1/A | Registration statement, amended | 0001104659-24-081008 |
| 2024-07-1614:41 ET | S-1/A | Registration statement, amended | 0001104659-24-080179 |
| 2024-06-2112:47 ET | S-1/A | Registration statement, amended | 0001104659-24-073848 |
| 2024-06-1107:01 ET | S-1/A | Registration statement, amended | 0001104659-24-070185 |
| 2024-05-2416:59 ET | S-1 | Registration statement | 0001104659-24-065172 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 09:37 ET. Listed shows no prices and gives no investment advice.